What is amazing is that we are seeing the continua
Post# of 9144
Posted On: 12/08/2016 6:16:46 PM
What is amazing is that we are seeing the continuation of the pattern in which no matter how good the Company's news might be there is an "eerie" attack on share price. For those who continually complain about not having news and information about what is going on the price reduction attacks demonstrate why it does not make sense for the Company to share information. What was just provided about the expansion strategy and what we heard several weeks ago about the quality of the N-Assay and the fact that it is a "disruptive" technology should at a minimum stabilize the share price. What we see, however, is that no announcement is satisfactory for the bashers because as has been indicated they are either paid to undermine the company or have an insane personal gripe about the CEO or someone else associated with NanoLogix. Providing financials is clearly not the answer because that would simply trigger another round of attacks by people either financially interested in sabotage or pathologically twisted in the way several posters on this board and the other two boards have demonstrated.
The bottom line is that we have been provided strong information about a critical expansion strategy. This involves a significant investment of resources to make it happen and it is also clear that the process of transitioning to this production facility will take some time but is absolutely positive. Given the critical role of strategic information at this point and the fact that there are companies whose sales will be threatened by the N-Assay it would be crazy for the Company to share the kinds of financial, technical, strategic and sales information some posters are requesting or demanding. We have seen the technology. We have heard from disinterested medical professionals about just how unique and state of the art the N-Assay is. The Company has kept us informed of the timing and outlines of its expansion strategy. Enough said.
The bottom line is that we have been provided strong information about a critical expansion strategy. This involves a significant investment of resources to make it happen and it is also clear that the process of transitioning to this production facility will take some time but is absolutely positive. Given the critical role of strategic information at this point and the fact that there are companies whose sales will be threatened by the N-Assay it would be crazy for the Company to share the kinds of financial, technical, strategic and sales information some posters are requesting or demanding. We have seen the technology. We have heard from disinterested medical professionals about just how unique and state of the art the N-Assay is. The Company has kept us informed of the timing and outlines of its expansion strategy. Enough said.
(15)
(1)